These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12549987)

  • 21. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure.
    McKelvie R
    Clin Evid; 2004 Jun; (11):122-48. PubMed ID: 15652002
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.
    Jochmann N; Stangl K; Garbe E; Baumann G; Stangl V
    Eur Heart J; 2005 Aug; 26(16):1585-95. PubMed ID: 15996977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart failure.
    McKelvie R
    Clin Evid; 2004 Dec; (12):115-43. PubMed ID: 15865633
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy.
    Schaefer BM; Caracciolo V; Frishman WH; Charney P
    Heart Dis; 2003; 5(3):202-14. PubMed ID: 12783634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term management after myocardial infarction (Part 2.): Medical interventions].
    Czuriga I
    Orv Hetil; 2004 Dec; 145(52):2629-32. PubMed ID: 15724699
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of hypertension.
    Cuddy ML
    J Pract Nurs; 2006; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions with cardiovascular drugs.
    Opie LH
    Curr Probl Cardiol; 1993 Sep; 18(9):531-81. PubMed ID: 7900972
    [No Abstract]   [Full Text] [Related]  

  • 34. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drugs used in cardiovascular diseases and cytokines].
    Andrzejczak D; Górska D
    Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk and predictability of drug interactions in the elderly.
    Levy RH; Collins C
    Int Rev Neurobiol; 2007; 81():235-51. PubMed ID: 17433928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450-mediated cardiovascular drug interactions.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1065-82. PubMed ID: 21810031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.